2023
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
Rabiee A, Mahmud N, Falker C, Garcia-Tsao G, Taddei T, Kaplan D. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis. Hepatology Communications 2023, 7: e0093. PMID: 36972386, PMCID: PMC10043587, DOI: 10.1097/hc9.0000000000000093.Peer-Reviewed Original ResearchConceptsAlcohol-associated cirrhosisAlcohol use disorderUse disordersCause mortalityImproved survivalPropensity scoreInpatient diagnosis codesRetrospective cohort studyCox regression analysisActive alcohol useCirrhosis decompensationCohort studyConcurrent diagnosisLiver diseasePotential confoundersDiagnosis codesVeteran outcomesCirrhosis diagnosisStrong negative predictorCirrhosisPatientsHazardous drinkingAlcohol use behaviorsCosts AssociatedAlcohol use
2021
Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis
Saffo S, To UK, Santoiemma PP, Laurito M, Haque L, Rabiee A, Verna EC, Angarone MP, Garcia-Tsao G. Changes in Ascitic Fluid Polymorphonuclear Cell Count After Antibiotics Are Associated With Mortality in Spontaneous Bacterial Peritonitis. Clinical Gastroenterology And Hepatology 2021, 20: e1201-e1204. PMID: 34273564, PMCID: PMC11090177, DOI: 10.1016/j.cgh.2021.07.019.Peer-Reviewed Original Research
2020
Factors associated with health‐related quality of life in patients with cirrhosis: a systematic review
Rabiee A, Ximenes R, Nikayin S, Hickner A, Juthani P, Rosen RH, Garcia‐Tsao G. Factors associated with health‐related quality of life in patients with cirrhosis: a systematic review. Liver International 2020, 41: 6-15. PMID: 32998172, DOI: 10.1111/liv.14680.Peer-Reviewed Original ResearchConceptsHealth-related qualityPoor HRQOLMuscle crampsHepatic encephalopathyPoor sleepSystematic reviewPoor health-related qualityPatient-reported outcomesPoor social supportPatient-centered careFull-text screeningAdult patientsPoor HRQoL.Cirrhosis etiologyHRQoLCirrhosisGeneric instrumentsEligibility criteriaCognitive impairmentPatientsMajority of studiesIdentified factorsCrampsDemographic factorsFrailty
2017
Evaluation of a strategy for enrolling the families of critically ill patients in research using limited human resources
Turnbull AE, Hashem MD, Rabiee A, To A, Chessare CM, Needham DM. Evaluation of a strategy for enrolling the families of critically ill patients in research using limited human resources. PLOS ONE 2017, 12: e0177741. PMID: 28542632, PMCID: PMC5444627, DOI: 10.1371/journal.pone.0177741.Peer-Reviewed Original ResearchConceptsEligible patientsConsent ratesHealthcare proxyIntensive care unit patientsFamily membersLonger ICU stayCare unit patientsFamilies of patientsEligible family membersICU stayPrimary outcomeSecondary outcomesUnit patientsIll patientsClinical trialsPatientsEnrollment periodFamily presenceEligible familiesICUConsecutive daysSuccess rateZip codesWeeksImportant demographic differences
2013
Psychiatric aspects of primary immunodeficiency diseases: the parental study.
Abolhassani H, Aghamohammadi A, Pourjabbar S, Salehi Sadaghiani M, Nikayin S, Rabiee A, Imanzadeh A, Mahmmoodi Gharaei J, Arbabi M, Rezaei N. Psychiatric aspects of primary immunodeficiency diseases: the parental study. Iranian Journal Of Allergy Asthma And Immunology 2013, 12: 176-81. PMID: 23754357.Peer-Reviewed Original ResearchConceptsPID patientsPsychiatric aspectsComplications of treatmentPrimary immunodeficiency diseasesLong-term illnessPID groupPatient complaintsPsychiatric effectsImmunodeficiency diseaseSide effectsDisease consistPatientsIncurable diseaseReliable questionnaireSuccessful managementTotal scoreParental studiesDiseaseLonger durationSignificant differencesChildrenPsychological counselingComplaintsAnxietyGroup